External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Cure SMA 2026

We will be contributing to topics related to
-
11:30 AM
Duration 120mins Florida, USA
HINALEA 2: Baseline observations in a trial evaluating risdiplam in patients with SMA who experienced a plateau or decline in function after gene therapy
CJ Guittari, A Hahn, K Kotulska-Jozwiak, E Keto, K Gorni, Y Li
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Florida, USA
Patient- and caregiver-reported swallowing and feeding outcomes in individuals with SMA treated with risdiplam: A longitudinal analysis of the Cure SMA Community Update Survey
Sheila Shapouri, Robert Schuldt, Lisa Belter, Mary Curry, Helen Lin, Ksenija Gorni
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 AM
Duration 120mins Florida, USA
A long-term follow-up study of risdiplam (WeSMA study): 12-month results in adult participants with SMA
Sheila Seleri, Elise Lim, Erica Keto, Rushabh Shah, Sheila Shapouri
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Florida, USA
Fertility in Risdiplam-Treated Adult Males with Spinal Muscular Atrophy (SMA):
Sheila Shapouri, Sheila Seleri, Natan Bar-Chama, Shafeeq Ladha, Shereen Yap, Elise Lim, Rushabh Shah, Travis Dickendesher
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Florida, USA
Evaluating the Feasibility of Linking Clinical Trial Data to Real-World Data Using Tokenization in Spinal Muscular Atrophy: Insights from the WeSMA Trial
Rekha Shivapa, Abigail Alve, Sheila Seleri, Karen Sick, Kimberly Barnholt, Erica Keto, Thomas Vaccaro
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:10 PM
Duration 20mins Florida
Safety and pharmacodynamic effects of emugrobart in combination with risdiplam in ambulant and non-ambulant participants with SMA: MANATEE Part 1
L Servais, B T Darras, E Mercuri, J M Morrow, F Muntoni, R Abbas, C De Ford, S Fletcher, E Gaki, H Kletzl, M Kuthiala, R S Scalco, V Schlegel, K R Wagner, W Yeung, T Duong
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:30 PM
Duration 20mins Florida
Final results from the JEWELFISH study: 5-year risdiplam treatment in non-treatment-naïve individuals with SMA
C A Chiriboga, C Bruno, T Duong, D Fischer, M Scoto, E Mercuri,V Schlegel, K Gorni, H Kletzl, P Pordeli, E Gaki, F Warren, F Muntoni
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon